1.
The Impact Factor Analysis and the Value of Prognosis of Yin Deficiency Syndrome and Yang Deficiency Syndrome of Cirrhosis after Hepatitis B
乙肝后肝硬化失代偿期阴虚、阳虚两类证候的影响因子分析及对预后的判断价值
2.
Lamivudine treatment in patients with decompensated cirrhosis due to hepatitis B
拉米夫定治疗乙型肝炎后肝硬化失代偿期临床观察
3.
Entecavir therapy in patients with decompensated HBV-related cirrhosis
恩替卡韦治疗失代偿期乙型肝炎肝硬化
4.
An analysis on prognosis in 289 patients with decompensatory cirrhosis
289例失代偿期肝硬化患者预后分析
5.
Evaluate the prognosis and liver functional reserve of patients with decompensated liver cirrhosis
失代偿期肝硬化肝脏储备功能及预后的评估
6.
Analysis of MELD Score for Short Term Prognosis of Patients with Decompensated Cirrhosis;
MELD评分对失代偿期肝硬化短期预后的评价
7.
The short-term prognosis evaluation of 239 Chinese patients with decompensated liver cirrhosis
239例肝硬化失代偿期患者的短期预后评估
8.
Contrast research of two kind of nucleoside analogs on the treatment for decompensated cirrhosis due to chronic hepatiti B
两种核苷(酸)类似物治疗慢乙肝失代偿期肝硬化对比研究
9.
Antivirus treatment combined with traditional Chinese medicine enema in the treatment of hepatitis B cirrhosis in decompensation
乙型肝炎失代偿期肝硬化的抗病毒与中药灌肠联合治疗
10.
Telbivudine therapy for decompensated HBV-related cirrhosis
替比夫定治疗失代偿期乙型肝炎肝硬化临床观察
11.
Study on 48-week treatment of entecavir in patients with decompensated hepatitis B-induced cirrhosis
恩替卡韦治疗失代偿期乙型肝炎肝硬化48周疗效观察
12.
Analysis of Prognosis in Patients with Decompensated Cirrhosis by the Model for End-stage Liver Disease and Its Longitudinal Modifications;
终末期肝病模型及其变化对失代偿期肝硬化患者的预后分析
13.
Analysis of Model for End-stage Liver Disease Score and Prognosis on Patients with Decompensated Liver Cirrhosis
失代偿期肝硬化患者的MELD评分与预后分析
14.
A retrospective analysis on factors influencing the prognsis of decompensation cirrhosis in 176 cases
176例失代偿期肝硬化预后影响因素的回顾分析
15.
Child-Pugh's Score in Prediction of Prognosis of Patients with Decompensated Liver Cirrhosis
Child-Pugh分级对失代偿期肝硬化预后的评估
16.
The delta value of model of end stage liver disease in predicting the prognosis of patients with decompensated cirrhosis
终末期肝病模型评分差值对失代偿期肝硬化患者预后评估的价值
17.
Values of end-stage liver disease model in assessment of prognosis in patients with decompensated liver cirrhosis
终末期肝病模型评估失代偿期肝硬化患者预后的价值
18.
The analysis of prognosis of patients with decompensated liver cirrhosis using the criterion of the model for end-stage liver disease and Child-Pugh grading
终末期肝病模型及Child-Pugh分级对失代偿期肝硬化患者的预后分析